Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides

Journal of Clinical Pathology

Volumn 56, Issue 6, 2003, Pages 453-458

  Goteri, G ^a   Filosa, A ^a   Mannello, B ^a   Stramazzotti, D ^a   Rupoli, S ^a   Leoni, P ^a   Fabris, G ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD8 ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; SEX RATIO; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0037972305     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.6.453     Document Type: Article

References (29)

1. Hansen ER. Immunoregulatory events in the skin of patients with cutaneous T-cell lymphoma. Arch Dermatol 1996;132:554-61.
2. Burg G, Dummer R, Haeffner A, et al. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol 2001;137:949-52.
3. Ralfkiaer E, Wantzin GL, Mason DY, et al. Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Comparison with lorge plaque parapsoriasis and benign chronic dermatoses. Am J Clin Pathol 1985;84:610-19.
4. Ralfkiaer E. Immunohistological markers for the diagnosis of cutaneous lymphomas. Semin Diagn Pathol 1991;8:62-72.
5. Moll M, Reinhold U, Kukel S, et al. CD7-negative helper T cells accumulate in inflammatory skin lesions. J Invest Dermatol 1994;102:328-32.
6. Bakels V, van Oostveen JW, van der Putte SCJ, et al. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo T-cell lymphomas. Am J Pathol 1997;150:1941-9.
7. Verga M, Braverman IM. The use of immunohistologic analysis in differentiating cutaneous T-cell lymphoma from psoriasis and dermatitis. Arch Dermatol 1991;127:1503-10.
8. Ashton-Key M, Diss TC, Du MQ, et al. The value of the polymerase chain reaction in the diagnosis of cutaneous T-cell infiltrates. Am J Surg Pathol 1997;21:743-47.
9. Kikuchi A, Naka W, Harada T, et al. Parapsoriasis en plaques: its potential progression to malignant lymphoma. J Am Acad Dermatol 1993;29:419-22.
10. Glusac EJ. Of cells and architecture: new approaches to old criteria in mycosis fungoides. J Cutan Pathol 2001;24:169-74.
11. Guitart J, Kennedy J, Ronan S, et al. Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting. J Cutan Pathol 2001;28:174-83.
12. Vonderheid EC, Tan E, Sobel EL, et al. Clinical implications of immunologic phenotyping in cutaneous T-cell lymphoma. J Am Acad Dermatol 1987;17:40.
13. Hoppe RT, Medeiros J, Warnke RA, et al. CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol 1995;32:448-53.
14. Vermeer MH, Van Doorn R, Dukers D, et al. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas ligand and killing inhibitory receptors and their relationship with clinical behaviour. J Clin Oncol 2001;19:4322-9.
15. Fujita M, Horiguchi Y, Miyachi Y, et al. A subpopulation of Langerhan's cells (CD1a+Lag-) increased in the dermis of plaque lesions of mycosis fungoides. J Am Acad Dermatol 1991;25:491-9.
16. Meissner K, Michaelis K, Rehpenning W, et al. Epidermal Langerhan's cell densities influence survival in mycosis fungoides and Sezary syndrome. Cancer 1990;65:2069-73.
17. Hansen ER, Bang B, Larsen JK, et al. In cutaneous T cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared to uninvolved epidermis. Br J Dermatol 1994;131:780-8.
18. Bunn PA, Lamberg SI. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 1979;63:581.
19. Lamberg S, Green S, Byar D, et al. Clinical staging for cutaneous T-cell lymphoma. Ann Intern Med 1984;100:187.
20. Disse TC, Watts M, Pan LX, et al. The polymerase chain reaction in the demonstration of monoclonality in T-cell lymphomas. J Clin Pathol 1995;48:1045-50.
21. Rupoli S, Barulli S, Guiducci B, et al. Low dose interferon α2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicentric study. Haematologica 1999;84:809-13.
22. Edelson RL. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Ann N Y Acad Sci 2001;941:1-11.
23. Ni X, Hazarika P, Zhang C, et al. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape? Clin Cancer Res 2001;7:2682-92.
24. Zoi-Toli O, Vermeer MH, De Vries E, et al. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL. Br J Dermatol 2000;143:313-19.
25. Santucci M, Biggeri A, Feller AC, et al. Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. Am J Surg Pathol 2000;24:40-50.
26. Fivenson DP, Nickoloff BJ. Distinctive dendritic cell subsets expressing factor XIIIa, CD1a, CD1b and CD1c in mycosis fungoides and psoriasis. J Cutan Pathol 1995;22:223-8.
27. Jimbow K, Chiba M, Horikoshi T. Electron microscopic identification of Langerhan's cells in the dermal infiltrates of mycosis fungoides. J Invest Dermatol 1982;78:102-7.
28. Bagot M, Echchakir H, Mami-Chouaib F, et al. Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8 dim+ T-cell clones infiltrating o cutaneous T cell lymphoma. Blood 1998;11:4331-41.
29. Lüftl M, Feng A, Licha E, et al. Dendritic cells and apoptosis in mycosis fungoides. Br J Dermatol 2002;147:1171-9.